Description

Algerika (pregabalin) hard capsules 150 mg. №56

Ingredients:

Each hard capsule contains 150 mg of pregabalin.

Dosage:

The recommended dosage is as directed by a healthcare professional. It is typically taken orally with or without food.

Indications:

Algerika (pregabalin) is indicated for the management of neuropathic pain associated with diabetic peripheral neuropathy, postherpetic neuralgia, and fibromyalgia.

Contraindications:

Do not use Algerika (pregabalin) if you are allergic to pregabalin or any of the other ingredients in the capsules. It is also contraindicated in patients with heart problems.

Directions:

Follow the instructions provided by your healthcare provider carefully. Do not exceed the recommended dose.

Scientific Evidence:

Pregabalin, the active ingredient in Algerika, exerts its effects by binding to the alpha2-delta subunit of voltage-gated calcium channels in the central nervous system. This binding reduces the release of neurotransmitters, such as glutamate, noradrenaline, and substance P, thereby modulating pain signaling pathways.

Clinical trials have demonstrated the efficacy of pregabalin in reducing neuropathic pain and improving quality of life in patients with various chronic pain conditions. A study published in the Journal of Pain Research showed that pregabalin significantly reduced pain scores and improved sleep quality in patients with fibromyalgia.

Additional Information:

It is important to note that Algerika (pregabalin) may cause dizziness, drowsiness, and weight gain as common side effects. Patients should avoid driving or operating machinery until they know how this medication affects them.

Before starting Algerika, inform your healthcare provider about any medical conditions you have and any medications you are taking to avoid potential drug interactions.